# Desloratadine in Patients With Ulcerative Colitis

> **NCT07333716** · PHASE2 · RECRUITING · sponsor: **Tanta University** · enrollment: 44 (estimated)

## Conditions studied

- Ulcerative Colitis (UC)
- Ulcerative Colitis

## Interventions

- **DRUG:** Desloratadine
- **DRUG:** mesalamine

## Key facts

- **NCT ID:** NCT07333716
- **Lead sponsor:** Tanta University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-01-26
- **Primary completion:** 2027-02
- **Final completion:** 2027-03
- **Target enrollment:** 44 (ESTIMATED)
- **Last updated:** 2026-01-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07333716

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07333716, "Desloratadine in Patients With Ulcerative Colitis". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT07333716. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*